CIDRAP newsletters options
December 18, 2009
(CIDRAP News) The second wave of the H1N1 influenza pandemic continued to fade last week, as the number of states with widespread cases dropped to 11 and reported deaths in children also declined, the Centers for Disease Control and Prevention (CDC) said today.
The CDC also reported finding 15 more cases of oseltamivir (Tamiflu)resistant H1N1 viruses, but it said those instances remain rare.
Dec 18, 2009
(CIDRAP News) The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it, federal officials said today.
(CIDRAP News) Afghanistan, Azerbaijan, and Mongolia will be the first three countries to receive donated supplies of pandemic H1N1 vaccine funneled through the World Health Organization, the WHO announced today as it cautioned that it's too early to declare the pandemic over.
Dec 17, 2009
(CIDRAP News) Despite a dip in cases, H1N1 influenza has not gone away and could resurge, making continued vaccination critical, government and private health officials said today.
Speaking on a webcast for health care providers conducted by the Department of Heath and Human Services (HHS), the experts urged healthcare workers to take the vaccine themselves and to continue to push it out to patients.
(CIDRAP News) Novartis's pandemic H1N1 flu vaccine generated stronger immune responses when it was combined with an adjuvant than when used alone, though both formulations yielded good results, according to a report published by the New England Journal of Medicine.
Dec 16, 2009
(CIDRAP News) In its seventh annual report card on the nation's public health preparedness, the advocacy group Trust for America's Health (TFAH) praised the US response to the H1N1 influenza pandemic but also said it has exposed serious gaps in the ability to deal with public health emergencies.
(CIDRAP News) Sanofi has recalled four lots of its prefilled syringe pandemic vaccine for children ages 6 months through 35 months after its post-distribution monitoring found that antigen content dropped slightly below required levels, a problem that federal officials say isn't linked to any safety concerns.
As much as we'd all like to put behind us the tale of H1N1, the first influenza pandemic of this century, I'm afraid it's too soon to stamp the words "The End." What's more, I've reached a conclusion that the way we define severity—or lack thereof—is as antiquated as the egg technology we've used to produce a vaccine for 40-plus years.
Dec 14, 2009
(CIDRAP News) New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.
Dec 11, 2009
Dec 10, 2009
(CIDRAP News) Another month's worth of data on H1N1 influenza has led federal officials to more than double their estimates of total cases, hospitalizations, and deaths and to assert that the impact on children and younger adults has been far greater than that of a typical flu season.
North Korea confirms flu outbreak
